Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01641237 · ClinicalTrials.gov registry record · Phase 3
Effect of Fluoride in a Dentifrice on Remineralization of Erosive Lesions
A Phase 3 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 3
- Development phase
- 72
- Enrollment target
NCT01641237 is a Phase 3 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 72 participants.
The verdict
NCT01641237, a Phase 3 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 72 participants
- Enrollment target
Study Summary
The proposed study will evaluate the performance of fluoride delivered from a new dentifrice formulation without potassium nitrate. It will also evaluate the dose-response to fluoride by testing four dentifrices covering a range of sodium fluoride concentration.
Interventions
- DRUG sodium fluoride
- DRUG no added fluoride in a silica base
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2012-03 |
| Est. Completion | 2012-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01641237
The ClinicalTrials.gov registry entry for NCT01641237 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which sodium fluoride is the first listed.
NCT01641237 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01641237 about?
NCT01641237 is a clinical study titled "Effect of Fluoride in a Dentifrice on Remineralization of Erosive Lesions". The proposed study will evaluate the performance of fluoride delivered from a new dentifrice formulation without potassium nitrate. It will also evaluate the dose-response to fluoride by testing four dentifrices covering a range of sodium fluoride concentration.
What is the current status of trial NCT01641237?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 72 participants. The study started on 2012-03. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01641237?
The interventions under investigation include: sodium fluoride (DRUG), no added fluoride in a silica base (DRUG).
Who is sponsoring clinical trial NCT01641237?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.